The mandatory Phase 1 clinical trial in healthy volunteers in China precedes the inclusion of Chinese clinical sites by late 2026 into the single Global Phase 3 registration trial of BV100 in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback